Aline Mamo

936 total citations
27 papers, 743 citations indexed

About

Aline Mamo is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Aline Mamo has authored 27 papers receiving a total of 743 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 10 papers in Molecular Biology and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Aline Mamo's work include Colorectal Cancer Treatments and Studies (7 papers), Cancer Treatment and Pharmacology (4 papers) and Hepatocellular Carcinoma Treatment and Prognosis (3 papers). Aline Mamo is often cited by papers focused on Colorectal Cancer Treatments and Studies (7 papers), Cancer Treatment and Pharmacology (4 papers) and Hepatocellular Carcinoma Treatment and Prognosis (3 papers). Aline Mamo collaborates with scholars based in Canada, United States and Lebanon. Aline Mamo's co-authors include Guy Sauvageau, R. Keith Humphries, Unnur Þorsteinsdóttir, Janet J. Bijl, Evert Kroon, Lori Jerome, H. Jeffrey Lawrence, Mark Basik, Saima Hassan and Cristiano Ferrario and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Molecular and Cellular Biology.

In The Last Decade

Aline Mamo

24 papers receiving 735 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Aline Mamo Canada 12 474 167 160 98 92 27 743
Miyuki Bohgaki Japan 19 557 1.2× 219 1.3× 191 1.2× 73 0.7× 90 1.0× 28 1.1k
Pierre Sujobert France 12 453 1.0× 224 1.3× 114 0.7× 118 1.2× 80 0.9× 47 836
Iria Vázquez Spain 15 538 1.1× 192 1.1× 204 1.3× 37 0.4× 191 2.1× 24 782
Ernesto Díaz-Flores United States 15 558 1.2× 305 1.8× 198 1.2× 41 0.4× 84 0.9× 29 859
Nicolas Goardon France 16 470 1.0× 249 1.5× 160 1.0× 114 1.2× 223 2.4× 29 905
Maria Daniotti Italy 10 607 1.3× 323 1.9× 335 2.1× 90 0.9× 204 2.2× 11 1.2k
Melinda S. Gordon United States 10 394 0.8× 88 0.5× 195 1.2× 74 0.8× 251 2.7× 25 683
Vadym Zaberezhnyy United States 16 704 1.5× 351 2.1× 214 1.3× 49 0.5× 331 3.6× 25 1.1k
S. Fakharzadeh United States 5 607 1.3× 146 0.9× 544 3.4× 94 1.0× 114 1.2× 10 1.1k
Jo Ishizawa United States 18 664 1.4× 252 1.5× 248 1.6× 46 0.5× 129 1.4× 65 892

Countries citing papers authored by Aline Mamo

Since Specialization
Citations

This map shows the geographic impact of Aline Mamo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aline Mamo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aline Mamo more than expected).

Fields of papers citing papers by Aline Mamo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aline Mamo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aline Mamo. The network helps show where Aline Mamo may publish in the future.

Co-authorship network of co-authors of Aline Mamo

This figure shows the co-authorship network connecting the top 25 collaborators of Aline Mamo. A scholar is included among the top collaborators of Aline Mamo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aline Mamo. Aline Mamo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ferrario, Cristiano, et al.. (2024). A phase 2, single-arm trial evaluating 131I-PSMA-1095 targeted radioligand therapy for metastatic castration-resistant prostate cancer. Nuclear Medicine Communications. 45(8). 683–689. 3 indexed citations
2.
3.
Rho, Young Soo, et al.. (2017). Prognostic value of neutrophil-lymphocyte ratio in first line treatment for metastatic pancreatic adenocarcinoma. Annals of Oncology. 28. v258–v258. 1 indexed citations
4.
5.
Mamo, Aline, Young Soo Rho, Solmaz Sahebjam, et al.. (2016). Progression Pattern and Adverse Events with Bevacizumab in Glioblastoma. Current Oncology. 23(5). 468–471. 10 indexed citations
6.
Cavallone, Luca, Aline Mamo, Catherine Chabot, et al.. (2015). The Estrogen Receptor Cofactor SPEN Functions as a Tumor Suppressor and Candidate Biomarker of Drug Responsiveness in Hormone-Dependent Breast Cancers. Cancer Research. 75(20). 4351–4363. 41 indexed citations
7.
Rho, Young Soo, Aline Mamo, Marine Gilabert, et al.. (2015). Clinical Practice Patterns in Chemotherapeutic Treatment Regimens for Metastatic Colorectal Cancer. Clinical Colorectal Cancer. 15(2). 135–140. 27 indexed citations
8.
Xu, Yue, et al.. (2015). Quantifying Treatment Delays in Adolescents and Young Adults with Cancer at McGill University. Current Oncology. 22(6). 470–477. 12 indexed citations
9.
Stutz, Michael D., Aline Mamo, David Valenti, et al.. (2015). Real-Life Report on Chemoembolization Using DEBIRI for Liver Metastases from Colorectal Cancer. Gastroenterology Research and Practice. 2015. 1–6. 15 indexed citations
10.
Mamo, Aline, Gerald Batist, Michael Palumbo, et al.. (2013). A Real-Life Experience Using Panitumumab in Chemo-Refractory Metastatic Colorectal Cancer Patients: A Retrospective Analysis at the Jewish General Hospital, 2009–2012. Current Oncology. 20(2). 107–112. 2 indexed citations
11.
Sauvageau, Guy, Unnur Thorsteinsdottir, Aline Mamo, et al.. (2013). marrow cells induces stem cell expansion associatedHoxa9 gene in bone - Overexpression of the myeloid leukemia.
12.
Bouganim, Nathaniel, Aline Mamo, Gerald Batist, et al.. (2013). Bevacizumab-Based Therapy for Colorectal Cancer: Experience from a Large Canadian Cohort at the Jewish General Hospital between 2004 and 2009. Current Oncology. 20(5). 247–251.
13.
Mamo, Aline, Luca Cavallone, Şükrü Tüzmen, et al.. (2011). An integrated genomic approach identifies ARID1A as a candidate tumor-suppressor gene in breast cancer. Oncogene. 31(16). 2090–2100. 100 indexed citations
14.
Hassan, Saima, Cristiano Ferrario, Aline Mamo, & Mark Basik. (2008). Tissue microarrays: emerging standard for biomarker validation. Current Opinion in Biotechnology. 19(1). 19–25. 50 indexed citations
15.
16.
Ferrario, Cristiano, et al.. (2006). Expression of neuropilin-1 and related proteins in breast cancer.. 66. 1182–1182. 3 indexed citations
17.
Jolivet, Jacques, et al.. (1996). Biochemical and Molecular Studies of Human Methenyltetrahydrofolate Synthetase. Stem Cells. 14(1). 33–40. 14 indexed citations
18.
Jolivet, Jacques, et al.. (1996). Biochemical and Molecular Studies of Human Methenyltetrahydrofolate Synthetase. The Oncologist. 1(4). 248–253. 8 indexed citations
19.
Bertrand, Richard, M. Beauchemin, Aline Mamo, et al.. (1995). Cloning and characterization of the human 5,10-methenyltetrahydrofolate synthetase-encoding cDNA. Gene. 165(2). 307–311. 24 indexed citations
20.
Stéphan, E. & Aline Mamo. (1952). [New cases of trichinosis in Lebanon; grave neurologic involvement in one of the cases; value of muscular biopsy; treatment with ACTH].. PubMed. 5(4). 236–48. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Miyuki Bohgaki Breakdown of academic impact, for papers by Pierre Sujobert Breakdown of academic impact, for papers by Iria Vázquez Breakdown of academic impact, for papers by Ernesto Díaz-Flores Breakdown of academic impact, for papers by Nicolas Goardon Breakdown of academic impact, for papers by Maria Daniotti Breakdown of academic impact, for papers by Melinda S. Gordon Breakdown of academic impact, for papers by Vadym Zaberezhnyy Breakdown of academic impact, for papers by S. Fakharzadeh Breakdown of academic impact, for papers by Jo Ishizawa
Rankless by CCL
2026